This inventor holds 12 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Perseus Proteomics Inc., Genentech, Inc.. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gotenba, JP (2014)
- Tokyo, JP (2017)
- Kanagawa, JP (2011 - 2023)
Company Filing History:
12 out of 987 
2 out of 27 
1 out of 3,299 
Years Active: 2011-2025
Title: Yasuko Kinoshita: Innovator in Genetic Research
Introduction
Yasuko Kinoshita is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of genetic research, particularly in the development of genetically modified organisms for medical applications. With a total of 11 patents to her name, Kinoshita's work has the potential to impact cancer treatment and drug evaluation.
Latest Patents
Kinoshita's latest patents include groundbreaking inventions such as a gene-modified mouse that expresses human GPC3 polypeptide. This genetically modified non-human animal is designed to be deficient in the expression of an endogenous GPC3 polypeptide while expressing a human GPC3 polypeptide at a physiologically adequate level. The methods associated with this invention include producing these non-human animals and evaluating test substances using them as models. Additionally, she has developed methods for assessing the safety and therapeutic effects of substances on diseases, pharmacokinetics, and in vivo distribution. Another significant patent involves methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies. This invention provides compositions and methods for treating cancers by administering a PD-1 axis binding antagonist alongside an anti-GPC3 antibody.
Career Highlights
Throughout her career, Kinoshita has worked with notable companies, including Chugai Seiyaku Kabushiki Kaisha. Her innovative research has positioned her as a leader in her field, contributing to advancements in cancer treatment and genetic engineering.
Collaborations
Kinoshita has collaborated with esteemed colleagues such as Takahiro Ishiguro and Toshihiko Ohtomo. These partnerships have further enhanced her research and development efforts in genetic modifications and therapeutic applications.
Conclusion
Yasuko Kinoshita's contributions to genetic research and cancer treatment through her innovative patents highlight her as a key figure in the scientific community. Her work continues to pave the way for advancements in medical science and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile